{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:38:12Z","timestamp":1765827492307},"reference-count":46,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2177\/jsci.39.190","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T20:46:29Z","timestamp":1466109989000},"page":"190-196","source":"Crossref","is-referenced-by-count":13,"title":["Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation"],"prefix":"10.2177","volume":"39","author":[{"given":"Hiroyuki","family":"WAKIGUCHI","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"OHGA","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mizushima, Y., et al.: Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. <i>Ann Rheum Dis<\/i>. <b>41<\/b>: 263-267, 1982.","DOI":"10.1136\/ard.41.3.263"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Muller, M., et al.: The glucocorticoid receptor. <i>Biochim Biophys Acta<\/i>. <b>1088<\/b>: 171-182, 1991.","DOI":"10.1016\/0167-4781(91)90052-N"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pak, C.C., et al.: Liposomal delivery of biological response modifiers to macrophages. <i>Biotherapy<\/i>. <b>3<\/b>: 55-64, 1991.","DOI":"10.1007\/BF02175099"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mantovani, A., et al.: The chemokine system in diverse forms of macrophage activation and polarization. <i>Trends Immunol<\/i>. <b>25<\/b>: 677-686, 2004.","DOI":"10.1016\/j.it.2004.09.015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sindrilaru, A., et al.: An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. <i>J Clin Invest<\/i>. <b>121<\/b>: 985-997, 2011.","DOI":"10.1172\/JCI44490"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nishiwaki, S., et al.: Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. <i>Blood<\/i>. <b>114<\/b>: 3113-3116, 2009.","DOI":"10.1182\/blood-2009-03-209635"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mantovani, A., et al.: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. <i>Trends Immunol<\/i>. <b>23<\/b>: 549-555, 2002.","DOI":"10.1016\/S1471-4906(02)02302-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fuentes-Duculan, J., et al.: A subpopulation of CD163-positive macrophages is classically activated in psoriasis. <i>J Invest Dermatol<\/i>. <b>130<\/b>: 2412-2422, 2010.","DOI":"10.1038\/jid.2010.165"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nishiwaki, S., et al.: Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions. <i>PLoS One<\/i>. <b>9<\/b>: e96252, 2014.","DOI":"10.1371\/journal.pone.0096252"},{"key":"10","unstructured":"10) Yokoyama, K., et al.: Development of a corticosteroid incorporated in lipid microspheres (liposteroid). <i>Drugs Exp Clin Res<\/i>. <b>11<\/b>: 611-620, 1985."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nishiwaki, S., et al. Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy. <i>Int J Hematol<\/i>. <b>95<\/b>: 428-433, 2012.","DOI":"10.1007\/s12185-012-1023-z"},{"key":"12","unstructured":"12) \u5ca9\u4e95\u6b63\u548c\uff0c\u4ed6\uff1a\u8102\u6eb6\u6027\u30d7\u30ed\u30c9\u30e9\u30c3\u30b0\uff0c\u30d1\u30eb\u30df\u30c1\u30f3\u9178\u30c7\u30ad\u30b5\u30e1\u30bf\u30be\u30f3\u306e\u751f\u4f53\u5185\u52d5\u614b\uff0e\u57fa\u790e\u3068\u81e8\u5e8a <b>19<\/b>: 619-658, 1985."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yamamoto, H., et al.: A new trial liposteroid (dexamethasone palmitate) therapy for intractable epileptic seizures in infancy. <i>Brain Dev<\/i>. <b>29<\/b>: 421-424, 2007.","DOI":"10.1016\/j.braindev.2006.12.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Daull, P., et al.: A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. <i>J Ocul Pharmacol Ther<\/i>. <b>29<\/b>: 258-269, 2013.","DOI":"10.1089\/jop.2012.0044"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ohga, S., et al.: Idiopathic pulmonary haemosiderosis in Japan: 39 possible cases from a survey questionnaire. <i>Eur J Pediatr<\/i>. <b>154<\/b>: 994-995, 1995.","DOI":"10.1007\/BF01958645"},{"key":"16","unstructured":"16) Ohga, S., et al.: Diagnosis and management of IPH\u2014idiopathic pulmonary hemosiderosis\u2014current diagnosis and management. <i>Int J Pediat Hem Onc<\/i>. <b>4<\/b>: 161-170, 1997."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ohga, S., at al.: Liposteroid against refractory pulmonary haemorrhage in idiopathic pulmonary haemosiderosis. <i>Eur J Pediatr<\/i>. <b>153<\/b>: 687-690, 1994.","DOI":"10.1007\/BF02190693"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Doi, T., et al.: Erratum to: Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. <i>Eur J Pediatr<\/i>. <b>174<\/b>: 1701, 2015.","DOI":"10.1007\/s00431-015-2638-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Doi, T., et al.: Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. <i>Eur J Pediatr<\/i>. <b>172<\/b>: 1475-1481, 2013.","DOI":"10.1007\/s00431-013-2065-9"},{"key":"20","unstructured":"20) Hoshi, K., et al.: Double-blind study with liposteroid in rheumatoid arthritis. <i>Drugs Exp Clin Res<\/i>. <b>11<\/b>: 621-626, 1985."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mizushima, Y., et al.: Targeting steroid therapy in rheumatoid arthritis. <i>Ann Rheum Dis<\/i>. <b>42<\/b>: 479-480, 1983.","DOI":"10.1136\/ard.42.4.479"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nakagishi, Y., et al.: Successful therapy of macrophage activation syndrome with dexamethasone palmitate. <i>Mod Rheumatol<\/i>. in press.","DOI":"10.3109\/14397595.2014.906053"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Wakiguchi, H., et al.: Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. <i>Pediatr Rheumatol Online J<\/i>. <b>13<\/b>: 49, 2015.","DOI":"10.1186\/s12969-015-0048-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shimizu, M., et al.: Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. <i>Clin Immunol<\/i>. <b>146<\/b>: 73-76, 2013.","DOI":"10.1016\/j.clim.2012.11.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Funauchi, M., et al.: Effects of liposteroid on the hemophagocytic syndrome in systemic lupus erythematosus. <i>Lupus<\/i>. <b>12<\/b>: 483-485, 2003.","DOI":"10.1191\/0961203303lu373oa"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kobayashi, Y., et al: Successful treatment with liposteroid followed by reduced intensity stem cell transplantation in an infant with perforin deficiency presenting with hemophagocytic lymphohistiocytosis. <i>J Pediatr Hematol Oncol<\/i>. <b>29<\/b>: 178-182, 2007.","DOI":"10.1097\/MPH.0b013e3180335030"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Arai, C., et al.: Neonatal herpes simplex type II virus infection complicated with meningitis and virus-associated hemophagocytic syndrome. <i>Nihon Rinsho Meneki Gakkai Kaishi<\/i>. <b>35<\/b>: 87-91, 2012.","DOI":"10.2177\/jsci.35.87"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Bonanomi, M.H., et al.: Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis. <i>Rheumatol Int<\/i>. <b>7<\/b>: 203-212, 1987.","DOI":"10.1007\/BF00541378"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lin, C.I., et al.: Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. <i>Clin Rheumatol<\/i>. <b>31<\/b>: 1223-1230, 2012.","DOI":"10.1007\/s10067-012-1998-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Behrens, E.M., et al.: Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. <i>J Clin Invest<\/i>. <b>121<\/b>: 2264-2277, 2011.","DOI":"10.1172\/JCI43157"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shimizu, M., et al.: Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. <i>Rheumatology (Oxford)<\/i>. <b>49<\/b>: 1645-1653, 2010.","DOI":"10.1093\/rheumatology\/keq133"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Grom, A.A.: Macrophage activation syndrome. <i>Textbook of Pediatric Rheumatology<\/i>, 7th ed, Saunders Elsevier, Philadelphia, 642-649, 2016.","DOI":"10.1016\/B978-0-323-24145-8.00049-1"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Yasumi, T., et al.: Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis. <i>Br J Haematol<\/i>. <b>170<\/b>: 532-538, 2015.","DOI":"10.1111\/bjh.13461"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) de Jager, W., et al.: Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. <i>Arthritis Rheum<\/i>. <b>60<\/b>: 2782-2793, 2009.","DOI":"10.1002\/art.24750"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Shimizu, M., et al.: Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. <i>Clin Immunol<\/i>. <b>160<\/b>: 277-281, 2015.","DOI":"10.1016\/j.clim.2015.06.005"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Henter, J.I., et al.: HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. <i>Pediatr Blood Cancer<\/i>. <b>48<\/b>: 124-131, 2007.","DOI":"10.1002\/pbc.21039"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Wakiguchi, H., et al. Overview of Epstein-Barr virus-associated diseases in Japan. <i>Crit Rev Oncol Hematol<\/i>. <b>44<\/b>: 193-202, 2002.","DOI":"10.1016\/S1040-8428(02)00111-7"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Nuesslein, T.G., et al.: Pulmonary haemosiderosis in infants and children. <i>Paediatr Respir Rev<\/i>. <b>7<\/b>: 45-48, 2006.","DOI":"10.1016\/j.prrv.2005.11.003"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Chryssanthopoulos, C., et al.: Prognostic criteria in idiopathic pulmonary hemosiderosis in children. <i>Eur J Pediatr<\/i>. <b>140<\/b>: 123-125, 1983.","DOI":"10.1007\/BF00441658"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Soergel, K.H., et al.: Idiopathic pulmonary hemosiderosisand related syndromes. <i>Am J Med<\/i>. <b>32<\/b>: 499-511, 1962.","DOI":"10.1016\/0002-9343(62)90051-7"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Kiper, N., et al.: Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979-1994): prolonged survival with low-dose corticosteroid therapy. <i>Pediatr Pulmonol<\/i>. <b>27<\/b>: 180-184, 1999.","DOI":"10.1002\/(SICI)1099-0496(199903)27:3<180::AID-PPUL5>3.0.CO;2-8"},{"key":"42","unstructured":"42) Sakurai, Y., et al.: Successful treatment with liposteroid in an infant case of idiopathic pulmonary hemosiderosis. <i>Jpn J Pediatr Hematol<\/i>. <b>9<\/b>: 42-46, 1995."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Richaud-Patin, Y., et al.: P-glycoprotein in autoimmune diseases. <i>Autoimmun Rev<\/i>. <b>3<\/b>: 188-192, 2004.","DOI":"10.1016\/j.autrev.2003.08.002"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Behrens, E.M., et al.: Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? <i>Autoimmun Rev<\/i>. <b>7<\/b>: 305-308, 2008.","DOI":"10.1016\/j.autrev.2007.11.025"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Matsubara, T., et al.: Immunological profile of peripheral blood lymphocytes and monocytes\/macrophages in Kawasaki disease. <i>Clin Exp Immunol<\/i>. <b>141<\/b>: 381-387, 2005.","DOI":"10.1111\/j.1365-2249.2005.02821.x"},{"key":"46","unstructured":"46) \u4f50\u6cbb\u3000\u52c9\uff0c\u4ed6\uff1a\u5ddd\u5d0e\u75c5\u6025\u6027\u671f\u6cbb\u7642\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\uff08\u5e73\u621024\u5e74\u6539\u8a02\u7248\uff09\uff0e\u65e5\u5c0f\u5faa\u8a8c <b>28<\/b>: 1-28, 2012."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u30ea\u30dd\u5316\u30b9\u30c6\u30ed\u30a4\u30c9\u7642\u6cd5\u306e\u81e8\u5e8a\u7684\u6709\u7528\u6027\uff1a\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u6d3b\u6027\u5316\u306b\u5bfe\u3059\u308b\u52b9\u679c\u3092\u4e2d\u5fc3\u306b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_190\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:31:55Z","timestamp":1498307515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_190\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.39.190","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}